COMMUNITY-ACQUIRED VS. VENTILATOR-ACQUIRED PNEUMONIA: A COMPARATIVE STUDY OF TREATMENT OUTCOMES

Abstract

Community-acquired pneumonia (CAP) and ventilator-acquired pneumonia (VAP) are significant causes of morbidity and mortality worldwide. Despite being distinct entities with different etiologies and risk factors, a comparative analysis of their treatment outcomes is crucial for optimizing patient care and resource allocation. This paper aims to review and analyze existing literature on the treatment outcomes of CAP and VAP, focusing on mortality rates, length of hospital stay, complications, recurrence rates, and prevention strategies. By understanding the similarities and differences in the management of these two types of pneumonia, healthcare providers can tailor treatment strategies to improve patient outcomes and reduce the burden of these infections.